Ventas Investment Management
Ventas Investment Management (VIM) consolidates our extensive third-party capital ventures under a single umbrella. Leveraging the full power of the experienced Ventas team to achieve superior results, including our long-tenured senior executives, VIM provides institutional investors with the opportunity to co-invest directly in life science, senior housing and other healthcare real estate while capitalizing on Ventas’s position as a trusted industry expert and innovator with a proven track record of success through market cycles.
With over $39 billion in strategic investments and a 20-year track record of providing 20+% compound annual returns to its public shareholders1, Ventas is a natural partner for globally respected institutional investors seeking to capitalize on the opportunity provided by demographically driven real estate.
The VIM Platform has $3.8 billion2 in assets under management and consists of the Ventas Life Science & Healthcare Real Estate Fund, our life science development joint venture with GIC and our senior housing development State Pension Fund joint venture.
Ventas resolutely aligns its interests with our investors:
- Co-Investment: Ventas maintains co-investment levels of at least 20% in each private capital venture. This provides real alignment of financial interests, as well as access to our entire suite of resources and relationships with industry leaders.
- A Single Portfolio: Ventas uses its enterprise-wide asset and property management teams, expertise and insights to manage its portfolio—whether wholly owned or VIM assets—with a single focus on optimizing performance of all assets.
Ventas Life Science and Healthcare Real Estate Fund, L.P: Ventas Life Science and Healthcare Real Estate Fund, L.P. is a perpetual life vehicle focused on investments in core and core plus life science, medical office and senior housing real estate in North America. As of March 15, 2021, the Fund has approximately $2.1 billion in assets under management consisting of nine premier life science facilities and one cutting-edge medical office building encompassing approximately 2.4 million square feet. Ventas is the Fund Sponsor and General Partner of the Fund.
GIC Research & Innovation Development Joint Venture: In October 2020, Ventas formed a joint venture with GIC, a leading global investment firm established to manage Singapore’s foreign reserves. The joint venture, of which Ventas is the manager, initially owned four university-based research and innovation development projects with total estimated project costs of approximately $930 million. The joint venture may be expanded to over $2 billion in assets through the addition of pre-identified future R&I development projects.
State Pension Fund Joint Venture: Principally focused on investment in ground up development and value added redevelopment of senior housing with premier operators, this joint venture exceeds $500 million in total assets and recently opened four state-of-the-art Class A senior housing communities in major metropolitan markets. Ventas serves as the managing member of the joint venture.
Managing Director and Portfolio Manager, Ventas Life Science & Healthcare Real Estate Fund; Ventas Portfolio Strategy Officer
Managing Director, Ventas Life Science and Healthcare Real Estate Fund; Vice President, Business Transformation
Director, Fund Finance, Ventas Life Science and Healthcare Real Estate Fund
Assistant General Counsel, Corporate & Securities
- Bloomberg, for the period beginning 12/31/1999 and ending 3/31/2021. Ventas prices adjusted historically for spin-off.
- As of 3/31/2021.